These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2099843)

  • 1. Recent clinical experience with tumor necrosis factor and advances in understanding its physiologic function and cellular activities.
    Silverman P; Berger NA
    Curr Opin Oncol; 1990 Dec; 2(6):1133-8. PubMed ID: 2099843
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor necrosis factor and lymphotoxin: endogenous antineoplastic mediators].
    Ketlinskiĭ SA; Belova LA
    Vopr Onkol; 1990; 36(4):396-402. PubMed ID: 2111959
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease?
    Matsuyama T; Kobayashi N; Yamamoto N
    AIDS; 1991 Dec; 5(12):1405-17. PubMed ID: 1814326
    [No Abstract]   [Full Text] [Related]  

  • 5. A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line.
    Meager A
    J Immunol Methods; 1991 Nov; 144(1):141-3. PubMed ID: 1960402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tumor necrosis factor and lymphotoxin: molecular genetics, regulation and physiological role].
    Nedospasov SA
    Genetika; 2003 Feb; 39(2):207-14. PubMed ID: 12669416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphotoxin and tumour necrosis factor as possible mediators of an inflammatory response.
    Ciba Found Symp; 1987; 131():185-91. PubMed ID: 3330010
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphotoxin and TNF differ greatly in capacity to induce differentiation of human myeloblastic leukemia ML-1 cells.
    Takeda K; Iwamoto S; Takeda M
    Biochem Mol Biol Int; 1994 Apr; 32(6):1109-19. PubMed ID: 8061628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TNF and lymphotoxin on the hematopoietic system.
    Trinchieri G
    Immunol Ser; 1992; 56():289-313. PubMed ID: 1550864
    [No Abstract]   [Full Text] [Related]  

  • 11. Some misconceptions about understanding autoimmunity through experiments with knockouts.
    Steinman L
    J Exp Med; 1997 Jun; 185(12):2039-41. PubMed ID: 9221283
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of abdominal temperature and circulating levels of cortisol and interleukin-6 in response to intra-arterial infusions of tumor necrosis factor-alpha or tumor necrosis factor-beta in guinea pigs.
    Goldbach JM; Roth J; Störr B; Zeisberger E
    Eur J Pharmacol; 1997 Sep; 334(2-3):249-54. PubMed ID: 9369355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha and lymphotoxin have opposite effects on sympathetic efferent nerves to brown adipose tissue by direct action in the central nervous system.
    Holt SJ; Grimble RF; York DA
    Brain Res; 1989 Sep; 497(1):183-6. PubMed ID: 2790452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes.
    Campbell IK; Piccoli DS; Roberts MJ; Muirden KD; Hamilton JA
    Arthritis Rheum; 1990 Apr; 33(4):542-52. PubMed ID: 2328032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disorders.
    Warzocha K; Salles G; Coiffier B
    Acta Haematol Pol; 1995; 26(4):323-32. PubMed ID: 8571733
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice.
    Thorbecke GJ; Shah R; Leu CH; Kuruvilla AP; Hardison AM; Palladino MA
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7375-9. PubMed ID: 1502148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioassay for tumor necrosis factors-alpha and -beta.
    Evans TJ
    Mol Biotechnol; 2000 Jul; 15(3):243-8. PubMed ID: 10986700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the hemopoietic system of mice deficient for tumor necrosis factor or lymphotoxin-alpha.
    Drize NI; Drutskaya MS; Gerasimova LP; Manakova TE; Chertkov IL; Turetskaya RL; Kuprash DV; Nedospasov SA
    Bull Exp Biol Med; 2000 Jul; 130(7):676-8. PubMed ID: 11140584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor: a master-regulator of leukocyte movement.
    Sedgwick JD; Riminton DS; Cyster JG; Körner H
    Immunol Today; 2000 Mar; 21(3):110-3. PubMed ID: 10689296
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons.
    Wallach D
    Interferon; 1986; 7():89-124. PubMed ID: 2434436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.